Granulocyte death mediated by specific antibodies in intravenous immunoglobulin (IVIG).
Sign Up to like & getrecommendations! Published in 2019 at "Pharmacological research"
DOI: 10.1016/j.phrs.2019.02.007
Abstract: Granulocytes are key effector cells of the innate immune system that cause substantial by-stander tissue damage in a broad range of inflammatory disorders. Specific antibodies with the potential to regulate granulocyte survival are present in… read more here.
Keywords: specific antibodies; granulocyte death; intravenous immunoglobulin; immunoglobulin ivig ... See more keywords
Pompholyx as a side effect of intravenous immunoglobulin (IVIg)
Sign Up to like & getrecommendations! Published in 2022 at "BMJ Case Reports"
DOI: 10.1136/bcr-2022-248772
Abstract: Intravenous immunoglobulin (IVIg) is increasingly used across multiple specialties for the treatment of inflammatory and autoimmune diseases. Cutaneous reactions to IVIg are generally minor. Pompholyx is a common eruption of small vesicles on the palms,… read more here.
Keywords: intravenous immunoglobulin; immunoglobulin ivig; side effect;
Nivolumab–ipilimumab combination therapy-induced seronegative encephalitis; rapid response to steroid plus intravenous immunoglobulin (IVIG) treatment
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Oncology Pharmacy Practice"
DOI: 10.1177/10781552221118529
Abstract: Introduction The efficacy of immune checkpoint inhibitors (ICIs) against malignant melanoma and numerously solid tumors has been demonstrated in several clinical studies. The incidence of immune-related adverse effects (irAEs) has increased after the rapidly expanding… read more here.
Keywords: encephalitis; immunoglobulin ivig; nivolumab ipilimumab; intravenous immunoglobulin ... See more keywords